EXCLUSIVE: Curanex Expands Drug Development Pipeline To Include Cancer Cachexia; Co's Phyto-N Currently Advancing Through Preclinical Studies To Prepare For Investigational New Drug Submission

Benzinga Newsdesk www.benzinga.com Positive 86.7%

Neg 0% Neu 0% Pos 86.7%

Comments

No comments yet. Be the first!